Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Plecanatide Patent Expiration

Plecanatide is Used for treating chronic idiopathic constipation, irritable bowel syndrome with constipation by increasing intracellular cGMP levels to improve intestinal function. It was first introduced by Salix Pharmaceuticals Inc in its drug Trulance on Jan 19, 2017.


Plecanatide Patents

Given below is the list of patents protecting Plecanatide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Trulance US10011637 Ultra-pure agonists of guanylate cyclase C, method of making and using same Jun 05, 2034 Salix
Trulance US11142549 Ultra-pure agonists of guanylate cyclase C, method of making and using same Jun 05, 2034 Salix
Trulance US11319346 Ultra-pure agonists of guanylate cyclase C, method of making and using same Mar 01, 2032 Salix
Trulance US11834521 Ultra-pure agonists of guanylate cyclase C, method of making and using same Jun 05, 2034 Salix
Trulance US7041786 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis Jan 30, 2028 Salix
Trulance US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis Jun 09, 2022

(Expired)

 Salix
Trulance US8637451 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis Mar 28, 2022

(Expired)

 Salix
Trulance US9610321 Formulations of guanylate cyclase C agonists and methods of use Sep 15, 2031 Salix
Trulance US9616097 Formulations of guanylate cyclase C agonists and methods of use Aug 20, 2032 Salix
Trulance US9919024 Formulations of guanylate cyclase C agonists and methods of use Sep 15, 2031 Salix
Trulance US9925231 Formulations of guanylate cyclase C agonists and methods of use Sep 15, 2031 Salix


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Plecanatide's patents.

Given below is the list recent legal activities going on the following patents of Plecanatide.

Event Date Patent/Publication
Patent litigations
Sequence Moved to Public Database 08 Dec, 2023 US11834521
Recordation of Patent eGrant 05 Dec, 2023 US11834521
Email Notification 05 Dec, 2023 US11834521
Recordation of Patent Grant Mailed 05 Dec, 2023 US11834521
Mail Patent eGrant Notification 05 Dec, 2023 US11834521
Patent Issue Date Used in PTA Calculation 05 Dec, 2023 US11834521
Patent eGrant Notification 05 Dec, 2023 US11834521
Email Notification 16 Nov, 2023 US11834521
Issue Notification Mailed 15 Nov, 2023 US11834521
Application Is Considered Ready for Issue 06 Nov, 2023 US11834521



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳